Nodes of Ranvier are the sites of saltatory conduction, which are a fundamental adaption of myelinated axons in the CNS and peripheral nervous system. Our understanding of the molecular organization of the nodal region has rapidly advanced. Many molecular components have been identified, as have the interactions among the axonal and glial molecules, accounting for the specialized features of nodal, paranodal, and juxtaparanodal domains (figure). With these discoveries, it is natural to consider whether molecules within the nodal complex act as antigens in autoimmune neuropathies, including Guillain-Barré syndrome (GBS). One set of candidates include the ezrin-radixin-moesin (ERM) complex family of cytoskeletal proteins, which are localized to the microvilli of myelinating Schwann cells and abut the nodal axolemma.
Nodes of Ranvier are the sites of saltatory conduction, which are a fundamental adaption of myelinated axons in the CNS and peripheral nervous system. Our understanding of the molecular organization of the nodal region has rapidly advanced. Many molecular components have been identified, as have the interactions among the axonal and glial molecules, accounting for the specialized features of nodal, paranodal, and juxtaparanodal domains (figure). With these discoveries, it is natural to consider whether molecules within the nodal complex act as antigens in autoimmune neuropathies, including Guillain-Barré syndrome (GBS). One set of candidates include the ezrin-radixin-moesin (ERM) complex family of cytoskeletal proteins, which are localized to the microvilli of myelinating Schwann cells and abut the nodal axolemma. 1 The current report identifies one member of this family, moesin (membrane-organizing extension spike protein), as a new antigen in GBS. 2 One of the great advances in our understanding of GBS was the delineation of clinical-pathologic phenotypes, the most common of which are acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN). In AMAN, the principal target antigens are GM1 and GD1a gangliosides, which are localized on the nodal axolemma and whose sugar sequences are also present in lipopolysaccharides of the Campylobacter jejuni strains that provide the initiating immunologic stimulus. Many gangliosides and other glycolipid species are widely expressed throughout glial and axonal plasma membranes in the nervous system where they may act as antigens. While diverse ganglioside and glycolipid antigens also appear to be prominent targets in AIDP, it is equally clear that for the majority of AIDP cases (and its chronic counterpart, chronic inflammatory demyelinating polyneuropathy [CIDP]), the targets remain unknown.
In the search for the "missing" AIDP and CIDP antigens, antibodies to proteins of the nodal region have been recently identified, including those to gliomedin, contactin, TAG-1, and neurofascin, each in small numbers of cases. [3] [4] [5] The current study adds to this effort. Sawai et al. 2 performed an unbiased search for new antigens by screening GBS sera against protein extracts from a Schwannoma cell line using 2-dimensional electrophoresis and Western blotting, and identified moesin. Screening other AIDP sera revealed a small proportion (6/40) to have anti-moesin antibodies, and, remarkably, 5 of 6 moesin-positive patients with AIDP had cytomegalovirus (CMV) as the preceding infection. Thus, these findings provide a strong link between post-CMV AIDP and anti-moesin antibodies, and reinforce the idea of "molecular mimicry" for GBS-that specific infections preceding AIDP drive infection-specific patterns of anti-nerve antibodies, as previously shown for C jejuni/Haemophilus influenza and gangliosides, and Mycoplasma pneumonia and galactocerebroside. 6, 7 Notwithstanding the potential importance of this finding, the authors acknowledge some of the limitations and unanswered questions arising from their brief report. The previously identified link between post-CMV AIDP and anti-GM2 antibodies remains undefined in the context of anti-moesin antibodies-are they coassociated biomarkers or arising independently? Antimoesin antibodies are also found in normal and disease control populations, including rheumatoid arthritis and aplastic anemia, raising questions about disease specificity. The presence of the ERM complex in many cell types calls into question how Schwann cells are specifically affected in AIDP, although a similar criticism could be equally applied to the anti-ganglioside antibody field, because the gangliosides are similarly ubiquitous. Because the ERM complex is wholly intracellular, its availability as an immunopathologically relevant primary target of autoantibodies needs consideration. Moesin-null mice appear to be normal, although myelinated axons were not studied 8 ; it is therefore unlikely that the loss of moesin per se is the mechanism, but rather the antibody-mediated degradation of nodal microvilli that would be implicated as mediating the nodal dysfunction, as documented in an experimental model of AMAN, in which antibodies to GM1 fix complement and disrupt the integrity of the node. 9 Finding new antigens that define biomarkers or even pathogenic pathways in inflammatory neuropathies are key to future progress. Whether or not the current report evolves to become a landmark study in post-CMV AIDP remains to be determined, but it plants another flag at the node of Ranvier as an important site for exploration in the search for the causes of inflammatory neuropathies.
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DISCLOSURE Figure Molecular components at the node of Ranvier
Schematic drawing shows some of the molecular components of the peripheral nervous system nodal region, which can be divided into the node, paranode, and juxtaparanode. At the node, gliomedin, Nr-CAM, and neurofascin (NF) 186 link the Schwann cell microvilli to the nodal axolemma. In the paranode, NF155 interacts with Caspr and contactin heterodimers to link the glial and axonal membranes. In the juxtaparanode, TAG-1 homodimers link the adaxonal Schwann cell membrane to the axonal membrane. In the internodal region, Necl4 interacts with Necl1, and myelin-associated glycoprotein (MAG) has several potential axonal ligands, including Nogo-66 receptor and gangliosides (not shown). The lipid bilayers of the axonal and glial plasma membranes of the different nodal regions contain ganglioside-and glycolipid-enriched microdomains that interact with and likely stabilize nodal protein domains. The precise molecular organization of these lipids at a molecular level is largely unknown and for simplicity they are not included in the cartoon. PSD 5 postsynaptic density.
